Financials Alliance Pharma plc

Equities

Market Closed - London S.E. Other stock markets 16:35:08 13/09/2024 BST			5-day change	1st Jan Change
43.85 ^GBX	+3.42%		+13.60%	+8.27%

09-02	Alliance Pharma plc Announces Termination of Jeyan Heper as Director	CI
08-12	EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx	AN

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	135.6	129.8	169.6	172	182.7	189	202	211
Change	-	-4.3%	30.7%	1.39%	6.21%	3.45%	6.86%	4.46%
EBITDA ¹	39.4	38.6	48.57	39.19	44.99	43.1	46.37	49.61
Change	-	-2.03%	25.84%	-19.31%	14.79%	-4.2%	7.59%	7%
EBIT ¹	37.45	36.83	45.64	35.67	41.86	40.18	43.3	46.52
Change	-	-1.65%	23.92%	-21.83%	17.35%	-4.02%	7.78%	7.43%
Interest Paid ¹	-4.6	-3.3	-3.418	-5.433	-10.47	-7.95	-5.975	-3.65
Earnings before Tax (EBT) ¹	31.08	13.02	18.16	5.208	-48.8	24.8	29.83	32.65
Change	-	-58.12%	39.5%	-71.32%	-	-	20.29%	9.45%
Net income ¹	25.01	8.027	7.319	0.936	-33.14	15.8	20.12	22.9
Change	-	-67.9%	-8.82%	-87.21%	-	-	27.37%	13.82%
Announcement Date	07/04/20	23/03/21	22/03/22	21/03/23	19/06/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2021 S1	2021 S2	2022 S1	2022 S2	2023 S1	2023 S2
Net sales ¹	78.63	88.8	78.76	90.46	82.44	100.3
Change	-	12.93%	-11.3%	14.84%	-8.87%	21.67%
EBITDA ¹	22.76	25.82	21.54	17.66	17.96	27.03
Change	-	13.46%	-16.59%	-18%	1.69%	50.52%
EBIT ¹	21.66	23.98	19.82	15.85	16.28	25.58
Change	-	10.74%	-17.34%	-20.04%	2.69%	57.18%
Charge d'intérêts ¹	-1.6	-1.862	-0.09	-3.41	-5.959	-4.512
Earnings before Tax (EBT) ¹	16.52	1.642	16.48	-11.27	6.236	-55.04
Change	-	-90.06%	903.78%	-	-	-
Net income ¹	8.24	-0.921	13.1	-12.17	5.109	-38.24
Change	-	-	-	-	-	-
Announcement Date	21/09/21	22/03/22	20/09/22	21/03/23	26/09/23	19/06/24

¹GBP in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	59.2	109	87	102	91.2	74.2	50.5	19.6
Change	-	84.12%	-20.18%	17.24%	-10.59%	-18.65%	-31.94%	-61.19%
Announcement Date	07/04/20	23/03/21	22/03/22	21/03/23	19/06/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	4.1	4.612	1.526	0.358	0.696	3.134	2.928	3.492
Change	-	12.49%	-66.91%	-76.54%	94.41%	350.26%	-6.58%	19.3%
Free Cash Flow (FCF) ¹	29.1	34.1	33.13	15.8	30.71	26.1	29.75	31.31
Change	-	17.18%	-2.85%	-52.3%	94.39%	-15.02%	13.99%	5.23%
Announcement Date	07/04/20	23/03/21	22/03/22	21/03/23	19/06/24	-	-	-

¹GBP in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	29.05%	29.74%	28.63%	22.79%	24.62%	22.8%	22.96%	23.51%
EBIT Margin (%)	27.61%	28.37%	26.9%	20.74%	22.91%	21.26%	21.44%	22.05%
EBT Margin (%)	22.91%	10.03%	10.7%	3.03%	-26.71%	13.12%	14.77%	15.47%
Net margin (%)	18.44%	6.18%	4.31%	0.54%	-18.14%	8.36%	9.96%	10.85%
FCF margin (%)	21.45%	26.27%	19.53%	9.19%	16.81%	13.81%	14.73%	14.84%
FCF / Net Income (%)	116.35%	424.82%	452.62%	1,688.03%	-92.69%	165.22%	147.86%	136.71%
Profitability
ROA	-	-	-	-	5.32%	2.85%	-	-
ROE	6.61%	9.78%	12.13%	8.1%	10.17%	7.51%	9%	11.4%
Financial Health
Leverage (Debt/EBITDA)	1.5x	2.83x	1.79x	2.6x	2.03x	1.72x	1.09x	0.4x
Debt / Free cash flow	2.03x	3.21x	2.63x	6.46x	2.97x	2.84x	1.7x	0.63x
Capital Intensity
CAPEX / Current Assets (%)	3.02%	3.55%	0.9%	0.21%	0.38%	1.66%	1.45%	1.66%
CAPEX / EBITDA (%)	10.41%	11.95%	3.14%	0.91%	1.55%	7.27%	6.31%	7.04%
CAPEX / FCF (%)	14.09%	13.52%	4.61%	2.27%	2.27%	12.01%	9.84%	11.16%
Items per share
Cash flow per share ¹	-	-	-	0.0385	0.058	0.0397	0.068	0.0637
Change	-	-	-	-	50.81%	-31.6%	71.49%	-6.31%
Dividend per Share ¹	0.00536	0.0161	0.0169	0.0178	-	0.00447	0.00476	-
Change	-	200.37%	5.03%	5.03%	-	-	6.49%	-
Book Value Per Share ¹	0.5179	0.5272	0.5248	0.5327	-	0.4229	0.5037	0.5136
Change	-	1.8%	-0.45%	1.5%	-	-	19.1%	1.98%
EPS ¹	0.0472	0.0152	0.0135	0.0017	-0.0613	0.0289	0.0373	0.0423
Change	-	-67.8%	-11.18%	-87.41%	-3,705.88%	-147.11%	29.16%	13.4%
Nbr of stocks (in thousands)	528,077	532,606	538,045	539,995	540,390	540,566	540,566	540,566
Announcement Date	07/04/20	23/03/21	22/03/22	21/03/23	19/06/24	-	-	-